Marizomib Central Nervous System (CNS)

NCT05050305 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study support withdrawn

Conditions

Multiple Myeloma
Multiple Myeloma in Relapse
Multiple Myeloma, Refractory

Interventions

DRUG: Marizomib
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]